| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2014 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JPMORGAN CHASE & CO. | 3 | Q2 2024 | 43.1% |
| ISHARES TR | 3 | Q2 2024 | 9.5% |
| VANGUARD WHITEHALL FDS | 3 | Q2 2024 | 7.5% |
| UNITEDHEALTH GROUP INC | 3 | Q2 2024 | 7.0% |
| VANGUARD SPECIALIZED FUNDS | 3 | Q2 2024 | 5.1% |
| JOHN HANCOCK EXCHANGE TRADED | 3 | Q2 2024 | 5.0% |
| SCHWAB STRATEGIC TR | 3 | Q2 2024 | 3.0% |
| FIRST TR EXCHNG TRADED FD VI | 3 | Q2 2024 | 3.2% |
| SPDR GOLD TR | 3 | Q2 2024 | 1.8% |
| VANGUARD INDEX FDS | 3 | Q2 2024 | 1.8% |
View FreeGulliver LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-13 |
| 13F-HR | 2024-08-13 |
| 13F-HR | 2024-08-13 |
| N-PX | 2024-08-13 |
View FreeGulliver LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.